Answers are grounded in this paper and cite their sources.
Background/Objectives: In thyroid cancer, high levothyroxine (LT4) doses may reflect intentional thyroid-stimulating hormone (TSH) suppression rather than impaired bioavailability. We assessed gastrointestinal and medication-related factors in relation to LT4 dose after accounting for treatment goals and body mass index (BMI). Methods: This cross-sectional study included 218 LT4-treated patients and 69 non-LT4 reference patients. A structured questionnaire captured gastrointestinal symptoms, comorbidities, medications, and administration timing. BMI was calculated from recorded height and weight. The main adjusted analysis was restricted to participants with clinician-assessed target achievement; exploratory models additionally used measured TSH categories. Multivariable models used HC3 robust standard errors. Results: Among LT4-treated patients, 201 (92.2%) had thyroid cancer, 81 (37.2%) reported gastrointestinal symptoms, 74 (33.9%) had at least one potential interfering factor, and 49 (22.5%) reported proton-pump inhibitor (PPI) use. Factor prevalence was comparable in the reference population after adjustment for age, sex, and BMI. In the BMI-adjusted model (n = 156), PPI use was not associated with higher LT4 dose (β = −0.031 µg/kg/day, 95% CI −0.193 to 0.131; p = 0.703). Intended TSH suppression was associated with higher dose (β = 0.420, 95% CI 0.269–0.570; p < 0.001), whereas BMI was inversely associated with dose per kilogram. An exploratory BMI-adjusted model accounting for measured TSH categories also showed no significant association with PPI exposure (n = 184, β = 0.024 µg/kg/day, 95% CI −0.122 to 0.169; p = 0.751). Conclusions: Potentially interfering factors were common but were not independently associated with higher dose requirements. LT4 dose in thyroid cancer should be interpreted in relation to therapeutic intent and anthropometry; PPI exposure alone was not a reliable marker of increased dose requirement.
No takes yet. Share an insight, caveat, or question.
Bowl et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: